Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;29(7):734-739.
doi: 10.1016/j.jsps.2021.05.005. Epub 2021 May 31.

Willingness of Middle Eastern public to receive COVID-19 vaccines

Rana Abu-Farha  1 , Tareq Mukattash  2 , Rania Itani  3 , Samar Karout  3 , Hani M J Khojah  4 , Asia Abed Al-Mahmood  5 , Karem H Alzoubi  2
Affiliations

Willingness of Middle Eastern public to receive COVID-19 vaccines

Rana Abu-Farha et al. Saudi Pharm J. 2021 Jul.

Abstract

Background: COVID-19 is a pacing pandemic that affected health systems, economy, and social life in the whole world. Currently, there is no treatment for it, but the world is in a race that yielded, in a relatively short time than usual, several approved, promising vaccines in the middle of a storm of debates because of the speed of their production and approval.

Objective: This study assessed the willingness of Middle Eastern Arab publics to receive COVID-19 vaccines and investigated the factors behind any reluctance to receive them.

Methods: A self-administered questionnaire was distributed through social media applications in four Arab countries (Jordan, Saudi Arabia, Lebanon, and Iraq). Participants' demographics, medical history, their experience with COVID-19, and their willingness to receive the available vaccines were obtained and analyzed.

Results: A total of 2,925 completed forms were included. Only 25% of the participants were willing to receive a vaccine while 33% were hesitant. Iraqis were the most willing to receive it while Jordanians were the least (35% and 17% of each country, respectively). Interestingly, 60% of the acceptors were ready to pay for the vaccine if not covered by governments. It was also found that American vaccines were preffered by 50% of the acceptors. However, 30% of acceptors were unsure of which vaccine is the best and 11% stated that any vaccine is good. Social media were the major source of information about COVID-19 and its vaccines. Finally, predictors of acceptance of the vaccines included living in Saudi Arabia and Iraq, being unmarried, having monthly income > $1,000, holding a medical degree, having high fear from COVID-19, feeling of being at risk of getting infected with COVID-19, and previous reception of influenza vaccine, whereas predictors of refusal included female sex and previous infection with COVID-19.

Conclusion: Middle Eastern Arabs are less likely to accept receiving the COVID-19 vaccines compared with non-Arabs. Health authorities in these countries are advised to intensify their awareness-raising activities about the vaccines while ensuring fair distribution of them.

Keywords: COVID-19 vaccine; Hesitancy; Middle East; Predictors; Willingness.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Abu Farha R., Alzoubi K., Khabour O., Alfaqi M. Exploring perception and hesitancy towards COVID-19 vaccine: a Study from Jordan. Hum. Vaccin. Immunother. (In press). 2021 doi: 10.1080/21645515.2021.1888633. - DOI - PMC - PubMed
    1. Ali S.H., Foreman J., Tozan Y., Capasso A., Jones A.M., DiClemente R.J. Trends and predictors of COVID-19 information sources and their relationship with knowledge and beliefs related to the pandemic: nationwide cross-sectional study. JMIR Public Health Surveill. 2020;6 doi: 10.2196/21071. - DOI - PMC - PubMed
    1. Asante L.A., Mills R.O. Exploring the socio-economic impact of COVID-19 pandemic in marketplaces in urban Ghana. Afr Spectr. 2020;55:170–181. doi: 10.1177/0002039720943612. - DOI
    1. Bartsch S.M., O'Shea K.J., Ferguson M.C. Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention. Am. J. Prev. Med. 2020;59:493–503. doi: 10.1016/j.amepre.2020.06.011. - DOI - PMC - PubMed
    1. Basheti I.A., El-hajji F., Nassar R. Pharmacists’ awareness of COVID-19 and perceptions of their roles, barriers, and roles of policymakers: exploring the Middle East and North Africa (MENA) Int. J. Clin. Pract. 2021;e14074 doi: 10.1111/ijcp.14074. - DOI - PMC - PubMed

LinkOut - more resources